# Flow Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flow-biotechnologies

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.flowbio.com
- Latest round: Seed (Aug 18, 2020)
- Investors on record: 2

## About

Flow Biotechnologies Ltd. specializes in hydration technology, offering innovative solutions that enhance athletes' performance through real-time fluid management and personalized insights.Flow Biotechnologies Ltd. is focused on advanced hydration technology, offering the FLOWBIO Sensor which provides real-time measurements of fluid and sodium loss during physical activities. Founded in 2020, the company is based in London, UK, and has engaged in one funding deal as of August 18, 2020. The company was co-founded by Giovanni Rovere and Stefan Van Der Fluit, with Stefan serving as the CEO. They have not undergone any significant pivots or changes in their business strategy since inception.FLOWBIO specializes in advanced hydration technology through its flagship product, the FLOWBIO Sensor. This innovative device accurately measures fluid and sodium loss in real-time during physical activities, allowing athletes to receive personalized hydration insights powered by its proprietary Advanced Hydration Intelligence (AHi) technology. The sensor captures sweat data and combines it with factors like exercise intensity and environmental conditions to provide tailored hydration recommendations, helping users optimize their performance and recovery. The main customer base consists of endurance athletes, including runners, cyclists, and triathletes, who seek to enhance their hydration strategies to prevent issues like cramping and dehydration. FLOWBIO's products are primarily marketed in high-performance sports markets across North America, Europe, and Asia, where athletes are increasingly recognizing the importance of precise hydration management.The revenue model for FLOWBIO revolves around direct-to-consumer sales facilitated through their online platform, where customers can purchase the FLOWBIO Sensor alongside associated services through the FLOWBIO App. This direct approach enables a streamlined transaction process, allowing customers to access advanced hydration insights and performance optimization tools. The company offers subscription plans for ongoing access to enhanced app features, supporting users in tracking their hydration needs over time. By engaging directly with athletes, FLOWBIO fosters relationships that encourage repeat purchases and subscription renewals, contributing to a consistent revenue stream from its technology and services. The company is well-positioned to capitalize on the growing market for personalized health and performance optimization solutions.Flow Biotechnologies Ltd. plans to leverage its recent Seed funding round from SOSV and HAX in July 2020 to support the development of new products, including enhancements to the FLOWBIO Sensor and its associated app features. They aim to expand into new markets, targeting regions in North America and Europe, with plans to launch by the end of 2021. The funding will be utilized to further develop technology and marketing strategies to support these growth initiatives.

## Funding rounds

- Seed, Aug 18, 2020 — SOSV, HAX

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- HAX — Seed